Across Massachusetts, a quiet financial catastrophe is forcing local governments to make agonizing choices. Cities, towns, and school districts are grappling with a “budget nightmare” driven by staggering health insurance premium hikes, which are typically rising between 10% and 20%, and in some extreme cases, up to 40%.
Editors note: South Shore News is going paid in April, subscribe now to make sure you don’t miss a story. Reach out for group or organizational pricing.
These double-digit cost increases are colliding head-on with Proposition 2½, the state law that caps annual property tax revenue growth at 2.5%. Because municipalities cannot easily raise taxes to absorb these health care shocks, they are being forced to gut municipal services, leave vacant positions unfilled, lay off teachers and librarians, or push for controversial property tax overrides. In 2024, Massachusetts recorded the highest employer-based family health insurance premiums in the United States, averaging $28,151—over $3,500 above the national average. When factoring in out-of-pocket costs, the average family’s healthcare burden surpasses $32,000 annually.
So, what the heck is going on? How can towns survive this? What is the state doing to help? And is there any hope for relief? Here is a breakdown of the municipal healthcare cost crisis.
What the Heck is Going On?
The current cost crisis is not the result of a single failure, but rather a “perfect storm” of colliding economic, clinical, and pharmacological factors.
The GLP-1 Explosion The single most dramatic accelerant of municipal healthcare costs is the explosive popularity of GLP-1 receptor agonist drugs, such as Ozempic, Wegovy, and Zepbound. Initially developed for diabetes and now widely prescribed for weight loss, these injectable medications can cost between $950 and $1,350 per month per patient. The rapid uptake of GLP-1s has single-handedly broken local insurance budgets. For example, the Hampshire County Group Insurance Trust (HCGIT) saw its pharmaceutical claims leap by 80% in just 18 months, draining its financial reserves from $20 million down to under $5 million. Similarly, the state’s Group Insurance Commission (GIC) was forced to request a historic $240 million emergency supplemental budget from the legislature, with $61 million directly attributed to GLP-1 cost growth.
A Post-Pandemic Utilization Surge Healthcare utilization has aggressively bounced back after the suppressed demand of the COVID-19 pandemic. Patients are accessing the healthcare system at higher rates and presenting with higher acuity—meaning they are sicker and require more complex, expensive care due to delayed screenings and elective procedures. In 2023, hospital outpatient department spending grew by 11%, driven by complex surgeries and high-cost infusion drugs.
Soaring Provider Rates and Labor Shortages The actual “unit cost” of care—what hospitals and doctors charge for a specific service—continues to skyrocket. Hospitals are demanding higher reimbursement rates from insurers to offset their own escalating costs for supplies and labor. Following the pandemic, an estimated 20% of nurses left the profession, forcing hospitals to rely on expensive contract staffing (travel nurses), which saw costs rise by 154%. Furthermore, well-resourced hospital systems have the market power to command exorbitant prices, leading to a 30% unit price increase for inpatient stays over the last four years.
The Federal Subsidy Cliff Compounding these pressures is the expiration of enhanced federal Premium Tax Credits (PTCs) under the Affordable Care Act, which are set to expire at the end of 2025. If these federal subsidies disappear, an estimated 337,000 Massachusetts residents could see their health insurance premiums double or triple, pushing more people onto the state’s safety net or back onto municipal employer-sponsored plans.
What Can Towns Do About It?
While municipalities cannot single-handedly fix the macroeconomic drivers of healthcare, they are actively utilizing a toolkit of local strategies to shield their budgets from complete collapse.
Leveraging Chapter 32B for Plan Design Changes The most powerful tool for towns is the Municipal Health Insurance Reform Act of 2011 (Chapter 32B, Sections 21–23). Before this law, any change to municipal health benefits required full collective bargaining with unions, making cost containment incredibly difficult. Chapter 32B allows a municipality to alter plan designs—such as increasing copays, raising deductibles, and implementing tiered provider networks—through a streamlined negotiation process with a Public Employee Committee (PEC). By introducing tiered networks that incentivize employees to use high-quality, lower-cost community hospitals, towns like Amesbury saw a 38% reduction in emergency room spending.
Switching Insurance Purchasing Groups Many municipalities are abandoning struggling regional insurance trusts and migrating to the state-run Group Insurance Commission (GIC). By pooling over 460,000 public employees and dependents, the GIC commands massive purchasing power to negotiate better rates with carriers. For fiscal year 2027, Malden is switching to the GIC to save an estimated $3 million. However, joining the GIC means local unions and officials surrender total control over plan design. Alternatively, some towns find better value in the Massachusetts Interlocal Insurance Association (MIIA), which experience-rates individual communities, allowing towns with healthy workforces to lock in lower premiums than they would get in a massive state pool.
Aggressive Utilization Management To combat the GLP-1 spending crisis, local governments and trusts are implementing strict utilization management. The town of Plymouth recently chose to stop covering GLP-1 drugs for general weight loss, a move expected to drop their projected premium increase from 14% down to 10%. The GIC and the HCGIT have also voted to eliminate or severely restrict GLP-1 weight-loss coverage to save millions of dollars and prevent even steeper premium hikes on employees.
Investing in Wellness and Preventive Care Towns are actively investing in the long-term health of their workforces to drive down claims. Through MIIA grants, communities like Cohasset have implemented comprehensive wellness programs covering everything from smoking cessation to cardiovascular health and free vision care.
What Can the State Do About It?
Recognizing that towns cannot simply “plan-design their way out of this,” the state government has recently deployed sweeping legislative and regulatory interventions.
New Drug Pricing and Private Equity Oversight In 2024, Governor Maura Healey signed Chapters 342 and 343 into law, giving the state unprecedented authority to intervene in the healthcare market. Chapter 342 (the PACT Act) caps copayments for life-saving chronic disease medications and establishes the Office of Pharmaceutical Policy and Analysis (OPPA) to monitor the opaque pricing practices of pharmacy benefit managers (PBMs). Chapter 343 targets private equity in healthcare, requiring state review of major healthcare transactions to prevent the kind of corporate mismanagement that led to the collapse of Steward Health Care.
Enforcing the Health Care Cost Growth Benchmark The state’s Health Policy Commission (HPC) sets an annual cost growth benchmark, establishing a 3.6% target for 2026. When providers or insurers exceed this benchmark, the HPC can require them to implement Performance Improvement Plans to force savings. However, many stakeholders, including major health plans, are demanding that the benchmark be given sharper “teeth” and strict financial consequences to force well-resourced hospital systems to rationalize their care and stop demanding exorbitant price increases.
Financial Safety Nets for Subsidies and Transitioning Towns To brace against the federal subsidy cliff, Governor Healey announced a $250 million investment from the Commonwealth Care Trust Fund to help shield vulnerable Massachusetts residents from losing their enhanced Premium Tax Credits. Furthermore, the state legislature passed a provision allowing communities fleeing financially devastated regional trusts (like HCGIT) to amortize their massive transition costs over five years, providing a crucial safety net for local budgets.
Is There Any Light at the End of the Tunnel?
The immediate outlook remains grim. Experts project that health insurance costs will continue to climb through at least 2032, keeping municipal budgets under intense pressure. However, there are significant glimmers of hope on the horizon.
First, federal relief is coming for pharmaceutical costs. Under the Inflation Reduction Act, the federal government has negotiated massive discounts on blockbuster drugs. The second round of these negotiations takes effect January 1, 2027, and drugs like Wegovy and Ozempic will see a 71% price reduction, which could drastically alter the financial trajectory of municipal health plans.
Second, structural reforms are on the table. Governor Healey has convened a Health Care Affordability Working Group, tasked with delivering long-term strategies to eliminate administrative waste, cap out-of-control provider pricing, and address system inefficiencies by June 2026. The legislature is also considering bold proposals, such as Senate Bill 868, which would grant the state the authority to set hard price ceilings on high-cost drugs, and S.867, which aims to shift healthcare spending heavily toward primary and preventive care.
Ultimately, resolving the municipal healthcare cost crisis will require moving beyond the “magical thinking” that infinite, high-cost care can be provided without financial consequence. It demands a fundamental rationalization of how care is delivered, a reduction in administrative bloat, and a commitment to “shared sacrifice” among hospitals, pharmaceutical companies, insurers, and the government. Massachusetts has a proud history of pioneering healthcare reform; it must now pioneer the path to healthcare sustainability.
Sources include: MassRetires, Massachusetts Municipal Association, Mass Budget, Mass Health Policy Commission, South Shore News, WBUR, GBH, The Boston Globe, The Daily Hampshire Gazette, The South Shore Times, Commonwealth Beacon, and AI Deep Research Tools
